Searchable abstracts of presentations at key conferences in endocrinology

ea0065p159 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Recurrent hyperparathyroidism in a patient with multiple endocrine neoplasia type 1 (MEN1) after total parathyroidectomy with autotransplantation unmasked by depression and vague abdominal pain

Alameri Majid , Fiad Tarek

Total parathyroidectomy with autotransplantation of parathyroid tissue is one of the treatment modalities for primary hyperparathyroidism in Multiple endocrine neoplasia type 1 (MEN1). Many of these patients are young and recurrence may take decades to emerge. We present a case of a 45-year-old woman who was diagnosed with MEN syndrome type 1 at the age of 12. Over the years, she underwent multiple surgical interventions including pituitary macroprolactinoma resection resultin...

ea0065p410 | Thyroid | SFEBES2019

Simultaneous occurrence of Graves’ disease in a monozygotic twin with type 1 diabetes

Alameri Majid , Alnuaimi Abdulla , Fiad Tarek

Graves’ disease is an autoimmune disorder of the thyroid gland. Patients with type 1 diabetes (T1DM) are at a higher risk of developing autoimmune diseases including thyroid disorders. To our knowledge, diagnosing Graves’ disease at the same time in a monozygotic twin with T1DM is a rare occurrence. We present a case of monozygotic female twin with T1DM, who both developed Graves’ disease at the same time. Type 1 diabetes was diagnosed in one of the twins (twin ...

ea0065p416 | Thyroid | SFEBES2019

Outcomes of Liraglutide as treatment for weight regain after bariatric surgery: A 2-year retrospective study

Alameri Majid , Alnuaimi Asma , Fiad Tarek

Introduction: Limited data is available on Liraglutide as a treatment option for weight regain after bariatric surgery. We aim to report the efficacy of Liraglutide as a treatment for weight regain in UAE population who underwent bariatric surgery.Methods: Retrospective analysis was performed on all patients with weight regain after bariatric surgery who received Liraglutide (dose range 0.6 up to 3.0 mg/day) while attending bariatric clinic of Sheikh Kha...

ea0022p450 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Unusual cause of hyercalcemia in pheochromocytoma

Katreddy Venkata M R , Ashawesh Khalid , Saraf Sanjay , Fiad Tarek M

Introduction: Hypercalcemia with pheochromocytoma usually occurs as part of MEN syndrome associated with parathyroid adenomas or hyperplasia. Here, we present a case of malignant pheochromocytoma with hypercalcemia caused by the secretion of PTHrP secretion tumour itself. Hypercalcemia was corrected on by the removal of the malignant pheochromocytoma.Case: A 75-year-old gentleman with PMHx of hypertension presented with a history of fall and head injury ...